Related references
Note: Only part of the references are listed.The emerging role of measurable residual disease detection in AML in morphologic remission
F. Buccisano et al.
SEMINARS IN HEMATOLOGY (2019)
Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group Experience
Francoise Solly et al.
CYTOMETRY PART A (2019)
CD34+CD38- leukemic stem cell frequency to predict outcome in acute myeloid leukemia
Wendelien Zeijlemaker et al.
LEUKEMIA (2019)
Refining AML outcome prediction
Christopher S. Hourigan et al.
LEUKEMIA (2019)
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
Gerrit J. Schuurhuis et al.
BLOOD (2018)
Molecular Minimal Residual Disease in Acute Myeloid Leukemia
M. Jongen-Lavrencic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Jacqueline Cloos et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Leukemic stem cells: identification and clinical application
Diana Hanekamp et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia
Adriana Plesa et al.
WORLD JOURNAL OF STEM CELLS (2017)
Prognostic impact of the CD34+/CD38-cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation
Madlen Jentzsch et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
The role of CD44 in fetal and adult hematopoietic stem cell regulation
Huimin Cao et al.
HAEMATOLOGICA (2016)
A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia
W. Zeijlemaker et al.
LEUKEMIA (2016)
The role of CD44 in fetal and adult hematopoietic stem cell regulation
Huimin Cao et al.
HAEMATOLOGICA (2016)
Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study
F. Lacombe et al.
LEUKEMIA (2016)
A 17-gene stemness score for rapid determination of risk in acute leukaemia
Stanley W. K. Ng et al.
NATURE (2016)
Direct confirmation of quiescence of CD34+CD38-leukemia stem cell populations using single cell culture, their molecular signature and clinicopathological implications
Eun Jeong Won et al.
BMC CANCER (2015)
Absence of leukaemic CD34+ cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy deciphered
Wendelien Zeijlemaker et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia
Monique Terwijn et al.
PLOS ONE (2014)
Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia
Keumrock Hwang et al.
ANNALS OF HEMATOLOGY (2012)
Aclinically relevant population of leukemic CD34+CD38- cells in acute myeloid leukemia
Jonathan M. Gerber et al.
BLOOD (2012)
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
T. Kalina et al.
LEUKEMIA (2012)
Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2R gamma c-deficient mice
Jean-Emmanuel Sarry et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cancer stem cells: mirage or reality?
Piyush B. Gupta et al.
NATURE MEDICINE (2009)
The novel AML stem cell-associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells
Anna van Rhenen et al.
BLOOD (2007)
High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival
A van Rhenen et al.
CLINICAL CANCER RESEARCH (2005)
Share Paper
